Article | October 30, 2024
Navigating Government Investigations: A Guide for FDA-Regulated Companies
Read More
Article | October 21, 2024
What the DOJ Looks For: Key Insights into Evaluating Your Compliance Program
Read More
Article | October 10, 2024
Gardner Law Launches Litigation Practice with Renowned Attorney David Graham
Read More
Article | October 01, 2024
Latest Untitled Letter from FDA’s OPDP Underscores Need for Careful Approach to Advertising
Read More
Article | September 05, 2024
Navigating the Biosecure Act: Implications for Biotechnology and Pharmaceutical Companies
Read More
Article | August 27, 2024
Kickbacks and Consequences: Lessons from the Innovasis Settlement
Read More
Article | August 14, 2024
FDA Faces Pressure to Enhance Oversight of Online Prescription Drug Promotions
Read More
Article | August 01, 2024
FDA Unveils Criteria for Reporting Real-World Evidence (RWE) Submissions
Read More
Article | July 10, 2024
Privacy Summer School: 10 Things You Should Know About Privacy, Consent, and HIPAA
Read More
Article | June 27, 2024
Expert Insights from In-House Lawyers: Navigating Legal and Regulatory Challenges
Read More